Merck to acquire Peloton in $1.05B cash-deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Tuesday, Merck & Co stated it would acquire the cancer drug developer Peloton Therapeutics in a cash deal valued at $1.05B, seeking to receive access to the firm's renal cancer medication candidate PT2977.
Back to articles

Actual Topics

Tue, 21 May 2019 11:35:05 GMT

Crane seeks acquiring Circor for $1.7B

Crane Co, the US industrial products maker, stated on Tuesday it had made an offer to acquire smaller competitor Circor International in a deal worth at $1.7B.

Tue, 21 May 2019 10:35:00 GMT

British factories experience decline

During the early hours of London's trading session the GBP/USD declined due to UK factories reporting a record decline in orders since late 2016.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.